nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylpropanolamine—MAOA—bipolar disorder	0.291	0.361	CbGaD
Phenylpropanolamine—DRD1—bipolar disorder	0.265	0.328	CbGaD
Phenylpropanolamine—SLC6A3—bipolar disorder	0.251	0.311	CbGaD
Phenylpropanolamine—SLC6A2—locus ceruleus—bipolar disorder	0.0097	0.165	CbGeAlD
Phenylpropanolamine—MAOA—locus ceruleus—bipolar disorder	0.00894	0.152	CbGeAlD
Phenylpropanolamine—DRD1—telencephalic ventricle—bipolar disorder	0.00709	0.12	CbGeAlD
Phenylpropanolamine—SLC6A3—telencephalic ventricle—bipolar disorder	0.0057	0.0967	CbGeAlD
Phenylpropanolamine—SLC6A2—autonomic nervous system—bipolar disorder	0.00515	0.0875	CbGeAlD
Phenylpropanolamine—CYP1A2—urine—bipolar disorder	0.00323	0.0548	CbGeAlD
Phenylpropanolamine—MAOA—blood plasma—bipolar disorder	0.00202	0.0343	CbGeAlD
Phenylpropanolamine—CYP1A2—blood plasma—bipolar disorder	0.00169	0.0286	CbGeAlD
Phenylpropanolamine—ADRA2A—blood plasma—bipolar disorder	0.00155	0.0263	CbGeAlD
Phenylpropanolamine—MAOA—adrenal cortex—bipolar disorder	0.00103	0.0174	CbGeAlD
Phenylpropanolamine—DRD1—nervous system—bipolar disorder	0.00101	0.0171	CbGeAlD
Phenylpropanolamine—SLC6A3—nervous system—bipolar disorder	0.000808	0.0137	CbGeAlD
Phenylpropanolamine—DRD1—brain—bipolar disorder	0.000769	0.013	CbGeAlD
Phenylpropanolamine—ADRB1—nervous system—bipolar disorder	0.000767	0.013	CbGeAlD
Phenylpropanolamine—SLC6A3—cerebellum—bipolar disorder	0.00076	0.0129	CbGeAlD
Phenylpropanolamine—MAOA—thyroid gland—bipolar disorder	0.000714	0.0121	CbGeAlD
Phenylpropanolamine—SLC6A2—nervous system—bipolar disorder	0.000652	0.0111	CbGeAlD
Phenylpropanolamine—SLC6A3—brain—bipolar disorder	0.000618	0.0105	CbGeAlD
Phenylpropanolamine—ADRA1A—nervous system—bipolar disorder	0.000606	0.0103	CbGeAlD
Phenylpropanolamine—MAOA—nervous system—bipolar disorder	0.000601	0.0102	CbGeAlD
Phenylpropanolamine—CYP1A2—thyroid gland—bipolar disorder	0.000596	0.0101	CbGeAlD
Phenylpropanolamine—ADRB1—brain—bipolar disorder	0.000586	0.00994	CbGeAlD
Phenylpropanolamine—ADRA1A—cerebellum—bipolar disorder	0.00057	0.00968	CbGeAlD
Phenylpropanolamine—MAOA—cerebellum—bipolar disorder	0.000565	0.00959	CbGeAlD
Phenylpropanolamine—Tranylcypromine—MAOA—bipolar disorder	0.000556	0.107	CrCbGaD
Phenylpropanolamine—ADRA2A—thyroid gland—bipolar disorder	0.000548	0.0093	CbGeAlD
Phenylpropanolamine—SLC6A2—brain—bipolar disorder	0.000498	0.00846	CbGeAlD
Phenylpropanolamine—Phentermine—MAOA—bipolar disorder	0.000466	0.0897	CrCbGaD
Phenylpropanolamine—ADRA1A—brain—bipolar disorder	0.000463	0.00786	CbGeAlD
Phenylpropanolamine—ADRA2A—nervous system—bipolar disorder	0.000461	0.00782	CbGeAlD
Phenylpropanolamine—MAOA—brain—bipolar disorder	0.000459	0.00779	CbGeAlD
Phenylpropanolamine—Pseudoephedrine—MAOA—bipolar disorder	0.000441	0.085	CrCbGaD
Phenylpropanolamine—ADRA2A—cerebellum—bipolar disorder	0.000434	0.00736	CbGeAlD
Phenylpropanolamine—Phentermine—SLC6A3—bipolar disorder	0.000401	0.0773	CrCbGaD
Phenylpropanolamine—Dextroamphetamine—SLC6A3—bipolar disorder	0.000383	0.0738	CrCbGaD
Phenylpropanolamine—Pseudoephedrine—SLC6A3—bipolar disorder	0.000381	0.0733	CrCbGaD
Phenylpropanolamine—Phenelzine—MAOA—bipolar disorder	0.00038	0.0731	CrCbGaD
Phenylpropanolamine—ADRA2A—brain—bipolar disorder	0.000352	0.00598	CbGeAlD
Phenylpropanolamine—Methamphetamine—MAOA—bipolar disorder	0.000332	0.0639	CrCbGaD
Phenylpropanolamine—Amphetamine—SLC6A3—bipolar disorder	0.000309	0.0594	CrCbGaD
Phenylpropanolamine—Phentermine—SLC6A4—bipolar disorder	0.0003	0.0578	CrCbGaD
Phenylpropanolamine—Methamphetamine—SLC6A3—bipolar disorder	0.000286	0.0551	CrCbGaD
Phenylpropanolamine—Pseudoephedrine—SLC6A4—bipolar disorder	0.000285	0.0548	CrCbGaD
Phenylpropanolamine—Amphetamine—SLC6A4—bipolar disorder	0.000231	0.0445	CrCbGaD
Phenylpropanolamine—Amphetamine—DRD2—bipolar disorder	0.00023	0.0442	CrCbGaD
Phenylpropanolamine—Methamphetamine—SLC6A4—bipolar disorder	0.000214	0.0412	CrCbGaD
Phenylpropanolamine—MAOA—Metabolism—CACNB2—bipolar disorder	2.95e-05	0.000228	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—ADCY2—bipolar disorder	2.92e-05	0.000226	CbGpPWpGaD
Phenylpropanolamine—MAOA—Metabolism—DPYD—bipolar disorder	2.9e-05	0.000224	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—DRD1—bipolar disorder	2.9e-05	0.000224	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—HTR2C—bipolar disorder	2.9e-05	0.000224	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR downstream signaling—ADCY2—bipolar disorder	2.89e-05	0.000224	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—DRD2—bipolar disorder	2.89e-05	0.000224	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—DRD3—bipolar disorder	2.87e-05	0.000222	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR ligand binding—HTR2A—bipolar disorder	2.87e-05	0.000222	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—ADM—bipolar disorder	2.86e-05	0.000221	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR downstream signaling—DRD2—bipolar disorder	2.86e-05	0.000221	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—NCAN—bipolar disorder	2.85e-05	0.000221	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR ligand binding—POMC—bipolar disorder	2.83e-05	0.000219	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR downstream signaling—ADCY2—bipolar disorder	2.83e-05	0.000219	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—DRD3—bipolar disorder	2.81e-05	0.000217	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR downstream signaling—DRD2—bipolar disorder	2.8e-05	0.000216	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—SLC5A3—bipolar disorder	2.8e-05	0.000216	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	2.8e-05	0.000216	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—TSHB—bipolar disorder	2.79e-05	0.000216	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—PDE4B—bipolar disorder	2.79e-05	0.000216	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—TACR1—bipolar disorder	2.79e-05	0.000216	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—DRD4—bipolar disorder	2.79e-05	0.000216	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—AKR1C4—bipolar disorder	2.78e-05	0.000215	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR ligand binding—POMC—bipolar disorder	2.77e-05	0.000214	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—DGKH—bipolar disorder	2.75e-05	0.000213	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—HTR1A—bipolar disorder	2.74e-05	0.000212	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—DRD4—bipolar disorder	2.73e-05	0.000211	CbGpPWpGaD
Phenylpropanolamine—MAOA—Metabolism—CACNA1C—bipolar disorder	2.7e-05	0.000209	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—TAC1—bipolar disorder	2.69e-05	0.000208	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR ligand binding—HTR2A—bipolar disorder	2.67e-05	0.000206	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—HTR2C—bipolar disorder	2.64e-05	0.000204	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—DRD1—bipolar disorder	2.64e-05	0.000204	CbGpPWpGaD
Phenylpropanolamine—MAOA—Metabolism—PIK3C2A—bipolar disorder	2.63e-05	0.000203	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—ADCY2—bipolar disorder	2.63e-05	0.000203	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—TRPC3—bipolar disorder	2.62e-05	0.000203	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—DRD2—bipolar disorder	2.6e-05	0.000201	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—ADCY2—bipolar disorder	2.57e-05	0.000199	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—DRD3—bipolar disorder	2.56e-05	0.000198	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—DGKH—bipolar disorder	2.56e-05	0.000198	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—HTR1A—bipolar disorder	2.54e-05	0.000197	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—DRD2—bipolar disorder	2.54e-05	0.000197	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—DRD5—bipolar disorder	2.52e-05	0.000195	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism of lipids and lipoproteins—CLOCK—bipolar disorder	2.51e-05	0.000194	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—TAC1—bipolar disorder	2.5e-05	0.000194	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—ADM—bipolar disorder	2.5e-05	0.000194	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Biological oxidations—POMC—bipolar disorder	2.49e-05	0.000193	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—HTR1A—bipolar disorder	2.49e-05	0.000192	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—DRD4—bipolar disorder	2.48e-05	0.000192	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—RGS4—bipolar disorder	2.47e-05	0.000191	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—HTR2C—bipolar disorder	2.46e-05	0.00019	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—DRD1—bipolar disorder	2.46e-05	0.00019	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—TAC1—bipolar disorder	2.45e-05	0.000189	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—TSHB—bipolar disorder	2.44e-05	0.000189	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—PDE4B—bipolar disorder	2.44e-05	0.000189	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—TACR1—bipolar disorder	2.44e-05	0.000189	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—HTR2C—bipolar disorder	2.4e-05	0.000186	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—DRD1—bipolar disorder	2.4e-05	0.000186	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—DRD3—bipolar disorder	2.38e-05	0.000184	CbGpPWpGaD
Phenylpropanolamine—MAOA—Metabolism—SNAP25—bipolar disorder	2.36e-05	0.000182	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—TRPC3—bipolar disorder	2.36e-05	0.000182	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—ADCY2—bipolar disorder	2.34e-05	0.000181	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—DRD5—bipolar disorder	2.34e-05	0.000181	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—DRD3—bipolar disorder	2.32e-05	0.00018	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—DRD2—bipolar disorder	2.31e-05	0.000179	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—HTR1A—bipolar disorder	2.31e-05	0.000179	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—DRD4—bipolar disorder	2.31e-05	0.000179	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—TRPC3—bipolar disorder	2.31e-05	0.000178	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—RGS4—bipolar disorder	2.29e-05	0.000177	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR ligand binding—POMC—bipolar disorder	2.29e-05	0.000177	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—TAC1—bipolar disorder	2.27e-05	0.000176	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—DRD4—bipolar disorder	2.26e-05	0.000175	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—ADM—bipolar disorder	2.25e-05	0.000174	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—HTR2C—bipolar disorder	2.23e-05	0.000172	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—DRD1—bipolar disorder	2.23e-05	0.000172	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR downstream signaling—HTR2A—bipolar disorder	2.23e-05	0.000172	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—IMPA1—bipolar disorder	2.23e-05	0.000172	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—ADM—bipolar disorder	2.2e-05	0.00017	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—TSHB—bipolar disorder	2.19e-05	0.00017	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—PDE4B—bipolar disorder	2.19e-05	0.00017	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—TACR1—bipolar disorder	2.19e-05	0.00017	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3C2A—bipolar disorder	2.18e-05	0.000168	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—ADCY2—bipolar disorder	2.17e-05	0.000168	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—DRD3—bipolar disorder	2.16e-05	0.000167	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—DRD2—bipolar disorder	2.15e-05	0.000166	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—PDE4B—bipolar disorder	2.14e-05	0.000166	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—TSHB—bipolar disorder	2.14e-05	0.000166	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—TACR1—bipolar disorder	2.14e-05	0.000166	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR ligand binding—POMC—bipolar disorder	2.13e-05	0.000165	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—ADCY2—bipolar disorder	2.12e-05	0.000164	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—DRD2—bipolar disorder	2.1e-05	0.000163	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—DRD4—bipolar disorder	2.1e-05	0.000162	CbGpPWpGaD
Phenylpropanolamine—MAOA—Metabolism—ADCY2—bipolar disorder	2.09e-05	0.000161	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—HTR2A—bipolar disorder	2.02e-05	0.000157	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—CLOCK—bipolar disorder	2.02e-05	0.000156	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—HTR1A—bipolar disorder	2.02e-05	0.000156	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR downstream signaling—HTR2A—bipolar disorder	2e-05	0.000155	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—TAC1—bipolar disorder	1.99e-05	0.000154	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—ADCY2—bipolar disorder	1.97e-05	0.000153	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—TSHB—bipolar disorder	1.97e-05	0.000152	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—TPH2—bipolar disorder	1.97e-05	0.000152	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—CACNB2—bipolar disorder	1.97e-05	0.000152	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR downstream signaling—HTR2A—bipolar disorder	1.96e-05	0.000152	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—DRD2—bipolar disorder	1.95e-05	0.000151	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—HTR2C—bipolar disorder	1.95e-05	0.000151	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—DPYD—bipolar disorder	1.94e-05	0.00015	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—TRPC3—bipolar disorder	1.91e-05	0.000148	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—NTRK2—bipolar disorder	1.9e-05	0.000147	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—NDUFV2—bipolar disorder	1.89e-05	0.000147	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—DRD3—bipolar disorder	1.89e-05	0.000146	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—GSK3A—bipolar disorder	1.88e-05	0.000145	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—AKR1C4—bipolar disorder	1.83e-05	0.000142	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—DRD4—bipolar disorder	1.83e-05	0.000142	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—ADM—bipolar disorder	1.82e-05	0.000141	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—HTR2A—bipolar disorder	1.82e-05	0.000141	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—HTR1A—bipolar disorder	1.81e-05	0.00014	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—CACNA1C—bipolar disorder	1.8e-05	0.000139	CbGpPWpGaD
Phenylpropanolamine—MAOA—Metabolism—COMT—bipolar disorder	1.79e-05	0.000138	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—TAC1—bipolar disorder	1.79e-05	0.000138	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR downstream signaling—POMC—bipolar disorder	1.78e-05	0.000138	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—HTR2A—bipolar disorder	1.78e-05	0.000138	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—HTR1A—bipolar disorder	1.77e-05	0.000137	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—TSHB—bipolar disorder	1.77e-05	0.000137	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—TACR1—bipolar disorder	1.77e-05	0.000137	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—PDE4B—bipolar disorder	1.77e-05	0.000137	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—TRPC3—bipolar disorder	1.77e-05	0.000137	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—PIK3C2A—bipolar disorder	1.76e-05	0.000136	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—HTR2C—bipolar disorder	1.75e-05	0.000136	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—DRD1—bipolar disorder	1.75e-05	0.000136	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—TAC1—bipolar disorder	1.75e-05	0.000135	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—ADCY2—bipolar disorder	1.72e-05	0.000133	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—TCF7L2—bipolar disorder	1.72e-05	0.000133	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—DRD1—bipolar disorder	1.71e-05	0.000133	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—HTR2C—bipolar disorder	1.71e-05	0.000133	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—DRD2—bipolar disorder	1.71e-05	0.000132	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—NTRK2—bipolar disorder	1.7e-05	0.000132	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—DRD3—bipolar disorder	1.7e-05	0.000131	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—ADM—bipolar disorder	1.69e-05	0.000131	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—GSK3A—bipolar disorder	1.69e-05	0.000131	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—NTRK2—bipolar disorder	1.67e-05	0.000129	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—DRD3—bipolar disorder	1.66e-05	0.000128	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—GSK3A—bipolar disorder	1.65e-05	0.000128	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—TSHB—bipolar disorder	1.65e-05	0.000127	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—PDE4B—bipolar disorder	1.65e-05	0.000127	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—TACR1—bipolar disorder	1.65e-05	0.000127	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—NR1D1—bipolar disorder	1.65e-05	0.000127	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—DRD4—bipolar disorder	1.65e-05	0.000127	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—HTR2A—bipolar disorder	1.62e-05	0.000125	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—POMC—bipolar disorder	1.62e-05	0.000125	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—DRD4—bipolar disorder	1.61e-05	0.000125	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR downstream signaling—POMC—bipolar disorder	1.6e-05	0.000124	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—NCAN—bipolar disorder	1.58e-05	0.000122	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—SNAP25—bipolar disorder	1.58e-05	0.000122	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR downstream signaling—POMC—bipolar disorder	1.57e-05	0.000121	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—ADCY2—bipolar disorder	1.55e-05	0.00012	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—NTRK1—bipolar disorder	1.55e-05	0.00012	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—TCF7L2—bipolar disorder	1.55e-05	0.00012	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—SLC5A3—bipolar disorder	1.54e-05	0.000119	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—DRD2—bipolar disorder	1.53e-05	0.000119	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—ADCY2—bipolar disorder	1.52e-05	0.000117	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—TCF7L2—bipolar disorder	1.51e-05	0.000117	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—HTR2A—bipolar disorder	1.51e-05	0.000117	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—S100B—bipolar disorder	1.5e-05	0.000116	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—DRD2—bipolar disorder	1.5e-05	0.000116	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—HTR2A—bipolar disorder	1.47e-05	0.000114	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—HTR1A—bipolar disorder	1.47e-05	0.000114	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—POMC—bipolar disorder	1.45e-05	0.000112	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—TAC1—bipolar disorder	1.45e-05	0.000112	CbGpPWpGaD
Phenylpropanolamine—MAOA—Metabolism—MTHFR—bipolar disorder	1.44e-05	0.000112	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—POMC—bipolar disorder	1.42e-05	0.00011	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—DRD1—bipolar disorder	1.42e-05	0.00011	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—HTR2C—bipolar disorder	1.42e-05	0.00011	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—ADCY2—bipolar disorder	1.39e-05	0.000108	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—NTRK1—bipolar disorder	1.39e-05	0.000107	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—NTRK2—bipolar disorder	1.38e-05	0.000107	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—DRD3—bipolar disorder	1.37e-05	0.000106	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—HTR2A—bipolar disorder	1.37e-05	0.000106	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—GSK3A—bipolar disorder	1.37e-05	0.000106	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—HTR1A—bipolar disorder	1.36e-05	0.000106	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—NTRK1—bipolar disorder	1.36e-05	0.000105	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—S100B—bipolar disorder	1.35e-05	0.000104	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—TAC1—bipolar disorder	1.34e-05	0.000104	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—DRD4—bipolar disorder	1.33e-05	0.000103	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—NRG1—bipolar disorder	1.33e-05	0.000103	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—S100B—bipolar disorder	1.32e-05	0.000102	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—HTR2C—bipolar disorder	1.32e-05	0.000102	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—DRD1—bipolar disorder	1.32e-05	0.000102	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—POMC—bipolar disorder	1.29e-05	0.0001	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—NTRK2—bipolar disorder	1.28e-05	9.91e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—DRD3—bipolar disorder	1.28e-05	9.87e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—GSK3A—bipolar disorder	1.27e-05	9.83e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—ADCY2—bipolar disorder	1.25e-05	9.71e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—TCF7L2—bipolar disorder	1.25e-05	9.67e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—DRD2—bipolar disorder	1.24e-05	9.61e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—DRD4—bipolar disorder	1.24e-05	9.58e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—POMC—bipolar disorder	1.2e-05	9.31e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—HTR2A—bipolar disorder	1.2e-05	9.25e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—COMT—bipolar disorder	1.19e-05	9.23e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—NRG1—bipolar disorder	1.19e-05	9.22e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—MAOA—bipolar disorder	1.19e-05	9.17e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—POMC—bipolar disorder	1.18e-05	9.09e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—NRG1—bipolar disorder	1.17e-05	9.02e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—ADCY2—bipolar disorder	1.17e-05	9.02e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—TCF7L2—bipolar disorder	1.16e-05	8.99e-05	CbGpPWpGaD
Phenylpropanolamine—MAOA—Metabolism—POMC—bipolar disorder	1.16e-05	8.94e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—DRD2—bipolar disorder	1.15e-05	8.92e-05	CbGpPWpGaD
Phenylpropanolamine—MAOA—Metabolism—INS—bipolar disorder	1.15e-05	8.89e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—NTRK1—bipolar disorder	1.12e-05	8.7e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—CLOCK—bipolar disorder	1.12e-05	8.63e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—S100B—bipolar disorder	1.09e-05	8.45e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—POMC—bipolar disorder	1.09e-05	8.45e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—TPH2—bipolar disorder	1.09e-05	8.41e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—TSHB—bipolar disorder	1.09e-05	8.41e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—CACNB2—bipolar disorder	1.09e-05	8.41e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—HTR2A—bipolar disorder	1.07e-05	8.31e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—DPYD—bipolar disorder	1.07e-05	8.28e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—HTR2A—bipolar disorder	1.05e-05	8.13e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—NTRK1—bipolar disorder	1.04e-05	8.08e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—S100B—bipolar disorder	1.02e-05	7.85e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—CACNA1C—bipolar disorder	9.95e-06	7.7e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—PIK3C2A—bipolar disorder	9.7e-06	7.5e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—MTHFR—bipolar disorder	9.65e-06	7.46e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—NRG1—bipolar disorder	9.65e-06	7.46e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—GSK3B—bipolar disorder	9.63e-06	7.45e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	9.57e-06	7.4e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—POMC—bipolar disorder	9.55e-06	7.39e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—INS—bipolar disorder	9.5e-06	7.34e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—NRG1—bipolar disorder	8.96e-06	6.93e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—HTR2A—bipolar disorder	8.7e-06	6.73e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—SNAP25—bipolar disorder	8.7e-06	6.73e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—GSK3B—bipolar disorder	8.65e-06	6.69e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—POMC—bipolar disorder	8.58e-06	6.64e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—INS—bipolar disorder	8.54e-06	6.6e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—GSK3B—bipolar disorder	8.47e-06	6.55e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—POMC—bipolar disorder	8.4e-06	6.5e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—INS—bipolar disorder	8.35e-06	6.46e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—HTR2A—bipolar disorder	8.08e-06	6.25e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—POMC—bipolar disorder	7.72e-06	5.97e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—ADCY2—bipolar disorder	7.7e-06	5.95e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—INS—bipolar disorder	7.68e-06	5.94e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—GSK3B—bipolar disorder	7e-06	5.42e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—POMC—bipolar disorder	6.95e-06	5.37e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—INS—bipolar disorder	6.91e-06	5.34e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—COMT—bipolar disorder	6.59e-06	5.1e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—MAOA—bipolar disorder	6.54e-06	5.06e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—GSK3B—bipolar disorder	6.51e-06	5.03e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—POMC—bipolar disorder	6.45e-06	4.99e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—INS—bipolar disorder	6.42e-06	4.96e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—MTHFR—bipolar disorder	5.33e-06	4.12e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—POMC—bipolar disorder	4.26e-06	3.3e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—INS—bipolar disorder	4.24e-06	3.28e-05	CbGpPWpGaD
